Insider Transactions Reported by 13 Insiders of Larimar Therapeutics, Inc.

Symbol
LRMR on Nasdaq
Location
Bala Cynwyd, PA

Insiders trading volume in the past year

Larimar Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James E. Flynn Director, * Director by Deputization, 10%+ Owner $99,120,550 +$30,000,000 +43% 31 Jul 2025
DEERFIELD PARTNERS, L.P. Director, Dir. by Deputization/10% Group, 10%+ Owner $10,367,497 16 Sep 2022
Thomas Edward Hamilton Director $6,329,779 13 May 2025
CAROLE BEN-MAIMON President and CEO, Director $3,491,254 22 Jan 2025
Michael Celano Chief Financial Officer $1,557,302 22 Jan 2025
Gopi Shankar Chief Development Officer $444,044 22 Jan 2025
Russell Clayton Chief Medical Officer $400,344 22 Jan 2025
Joseph Truitt Director 13 May 2025
FRANK E. THOMAS Director 13 May 2025
JEFFREY W. SHERMAN Director 13 May 2025
Peter Barrett Director 10 May 2022
JONATHAN S. LEFF Director 13 May 2025
Thomas O. Daniel Director 12 May 2021

Recent Insider Transactions by Companies or Individuals for Larimar Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.